RhumbLine Advisers’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-122,816
| Closed | -$79.9K | – | 4256 |
|
|
2025
Q1 | $79.9K | Sell |
122,816
-3,882
| -3% | -$2.53K | ﹤0.01% | 3460 |
|
|
2024
Q4 | $233K | Buy |
126,698
+7,320
| +6% | +$13.5K | ﹤0.01% | 3113 |
|
|
2024
Q3 | $413K | Buy |
119,378
+3,279
| +3% | +$11.3K | ﹤0.01% | 2836 |
|
|
2024
Q2 | $340K | Buy |
116,099
+21,935
| +23% | +$64.3K | ﹤0.01% | 2927 |
|
|
2024
Q1 | $532K | Buy |
94,164
+2,575
| +3% | +$14.5K | ﹤0.01% | 2636 |
|
|
2023
Q4 | $393K | Sell |
91,589
-309
| -0.3% | -$1.33K | ﹤0.01% | 2813 |
|
|
2023
Q3 | $319K | Buy |
91,898
+2,250
| +3% | +$7.81K | ﹤0.01% | 2898 |
|
|
2023
Q2 | $417K | Buy |
89,648
+4,952
| +6% | +$23K | ﹤0.01% | 2808 |
|
|
2023
Q1 | $391K | Buy |
84,696
+6,925
| +9% | +$32K | ﹤0.01% | 2523 |
|
|
2022
Q4 | $628K | Buy |
77,771
+6,787
| +10% | +$54.8K | ﹤0.01% | 2358 |
|
|
2022
Q3 | $394K | Buy |
70,984
+8,228
| +13% | +$45.7K | ﹤0.01% | 2605 |
|
|
2022
Q2 | $327K | Buy |
62,756
+7,580
| +14% | +$39.5K | ﹤0.01% | 2715 |
|
|
2022
Q1 | $454K | Sell |
55,176
-797
| -1% | -$6.56K | ﹤0.01% | 2467 |
|
|
2021
Q4 | $833K | Buy |
55,973
+737
| +1% | +$11K | ﹤0.01% | 2280 |
|
|
2021
Q3 | $1.04M | Buy |
55,236
+2,025
| +4% | +$38.2K | ﹤0.01% | 2213 |
|
|
2021
Q2 | $989K | Buy |
53,211
+23,960
| +82% | +$445K | ﹤0.01% | 2254 |
|
|
2021
Q1 | $666K | Buy |
29,251
+1,540
| +6% | +$35.1K | ﹤0.01% | 2362 |
|
|
2020
Q4 | $602K | Buy |
27,711
+7,201
| +35% | +$156K | ﹤0.01% | 2363 |
|
|
2020
Q3 | $206K | Buy |
20,510
+1,737
| +9% | +$17.4K | ﹤0.01% | 2673 |
|
|
2020
Q2 | $146K | Buy |
18,773
+4,975
| +36% | +$38.7K | ﹤0.01% | 2865 |
|
|
2020
Q1 | $141K | Hold |
13,798
| – | – | ﹤0.01% | 2696 |
|
|
2019
Q4 | $152K | Buy |
13,798
+220
| +2% | +$2.42K | ﹤0.01% | 2812 |
|
|
2019
Q3 | $123K | Buy |
13,578
+1,156
| +9% | +$10.5K | ﹤0.01% | 2854 |
|
|
2019
Q2 | $141K | Buy |
+12,422
| New | +$141K | ﹤0.01% | 2869 |
|